Off-label medications are a hot topic in the cancer world right now.
You’re hearing names like GLP-1s, ivermectin, and fenbendazole tossed around in comments, DMs, and late-night Google searches… but when you go looking for clear, trustworthy information?
So I brought in the best person I know for this conversation: Dr Paul Anderson. Dr. Anderson has spent decades working at the intersection of integrative medicine, complex chronic illness, and cancer.
One of the most important takeaways: the world of repurposed medications is much bigger than what’s trending on social media. There are many categories that researchers and clinicians explore in oncology, including:
diabetes medications statins (cholesterol medications) antibiotics antifungal medications antiviral medications, and moreIn this conversation, we focus on the ones people are asking about the most right now — GLP-1s and popular antiparasitics like ivermectin and fenbendazole — and we talk through what they do, why they’re being discussed, and what to watch for.
🔗 Episode Relevant Resources:
I highly recommend checking out Dr Anderson's books at https://dranow.com/ You can find Dr Anderson on Youtube: www.youtube.com/@DrA-Online E22 How To Block Cancer Recurrence by Changing The Tumor Neighbourhood: https://youtu.be/x9nQeqEPYzw E25 Does Sugar Really Feed Cancer?: https://youtu.be/XiWJ1betH5w E11 STOP Killing Cancer Cells - You’re Wasting Your Time. Do This Instead: https://youtu.be/3TP3jZ7T4fk⚠️ This is a must-listen if:
You keep hearing about off-label meds and feel unsure what’s real vs hype You want to reduce recurrence risk without taking a “throw everything at it” approach You’re curious about GLP-1s, ivermectin, or fenbendazole — but want context and safety You want to understand how these tools relate to the tumor microenvironment You want guidance that supports both your long-term health and your nervous system💊 In this episode, you’ll learn:
Why off-label medications are being explored in cancer care — and why this category is broader than most people realize What GLP-1s may suggest about cancer risk and longevity, and what we still don’t know yet Why antiparasitics like ivermectin and benzimidazoles (including fenbendazole) show up in oncology conversations How these drugs may influence the tumor microenvironment — and why that matters in recurrence prevention The key risks, limitations, and monitoring considerations that often get skipped online💡 You’ll leave this episode with:
A clearer way to think about off-label meds without fear-based urgency Better questions to ask before adding any medication to your plan A stronger understanding of why foundations (food, movement, metabolic health, muscle mass) still matter most More confidence in what’s worth exploring — and what’s probably notI’m Dr Megan, a licensed naturopathic doctor. My team and I support women after cancer with research-backed nutrition, lifestyle, and personalized strategies to reduce recurrence risk — so they can feel strong, clear, and supported in their next chapter.
Book a free Roadmap Call:
👉 https://www.flourishaftercancer.com/nextsteps
Instagram: @MeganBernardND
Facebook: @MeganBernardND
Website: https://www.flourishaftercancer.com
The information shared in this podcast is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Always consult with a qualified healthcare provider before making changes to medications, supplements, or lifestyle. This content is not a substitute for individualized medical advice or care.